Arrhythmic episodes in patients implanted with a cardioverter-defibrillator – results from the Prospective Study on Predictive Quality with Preferencing PainFree ATP therapies (4P)
Open Access
- 17 June 2019
- journal article
- research article
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 19 (1) , 1-12
Abstract
Little is known about the ICD performance using enhanced detection algorithms in unselected, non-trial patients. Performance of recent generation ICD equipped with SmartShock™ technology (SST) for detection and conversion of ventricular tachyarrhythmias (VTA) was investigated. 4P was a prospective, multicenter, observational study conducted in 10 Swiss implanting centers. Patients with a Class I indication according to international guidelines were included and received an ICD with SST. ICD discrimination capability was assessed by evaluating SST performance; therapy efficacy was assessed by rate of VTA conversions by ATP and by rescue shocks. Overall, 196 patients were included in the analysis with a mean duration of follow-up of 27.7 months (452 patient-years of observation). Patient-specific rather than recommended programming was preferred. Device-detected episodes were frequent (5147 episodes in 146 patients, 74.5%). In 44 patients (22.4%), 1274 episodes were categorized as VTA; only 215 episodes were symptomatic. ATP was the first-line therapy and highly effective (99.9% success rate at the episode level, 100.0% at the patient level). Rescue shocks were rare (66 episodes in 28 patients); 7 shocks in 5 patients (2.6%) were inappropriate. Death and hospitalization rates were low. In a cohort of non-trial, unselected ICD patients, VTA episodes were frequent. The 4P results confirm the robustness of VTA detection by SST and the effectiveness of ATP treatment, hence limiting overall ICD shock burden.Keywords
Funding Information
- Medtronic
This publication has 24 references indexed in Scilit:
- Combining Shock Reduction Strategies to Enhance ICD Therapy: A Role for Computer ModelingJournal of Cardiovascular Electrophysiology, 2010
- Appropriate Evaluation and Treatment of Heart Failure Patients After Implantable Cardioverter-Defibrillator DischargeJACC, 2009
- ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm AbnormalitiesJACC, 2008
- Improving SVT Discrimination in Single‐Chamber ICDs: A New Electrogram Morphology‐Based AlgorithmJournal of Cardiovascular Electrophysiology, 2006
- A Comparison of Empiric to Physician-Tailored Programming of Implantable Cardioverter-DefibrillatorsJACC, 2006
- Frequency and Causes of Implantable Cardioverter-Defibrillator Therapies: Is Device Therapy Proarrhythmic?The American Journal of Cardiology, 2006
- Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart FailureNew England Journal of Medicine, 2005
- Prospective Randomized Multicenter Trial of Empirical Antitachycardia Pacing Versus Shocks for Spontaneous Rapid Ventricular Tachycardia in Patients With Implantable Cardioverter-DefibrillatorsCirculation, 2004
- Antitachycardia Pacing for Ventricular Tachycardia Using Implantable Cardioverter Defibrillators:Pacing and Clinical Electrophysiology, 2004
- Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.Circulation, 1992